| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christoph Kraus, Eero Castrén, Siegfried Kasper, Rupert Lanzenberge. Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression. Neuroscience and biobehavioral reviews. vol 77. 2017-10-26. PMID:28342763. |
serotonin modulates neuroplasticity, especially during early life, and dysfunctions in both systems likewise contribute to pathophysiology of depression. |
2017-10-26 |
2023-08-13 |
Not clear |
| Christoph Kraus, Eero Castrén, Siegfried Kasper, Rupert Lanzenberge. Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression. Neuroscience and biobehavioral reviews. vol 77. 2017-10-26. PMID:28342763. |
with this review, we link preclinical with clinical work on serotonin and neuroplasticity to bring two pathophysiologic models in clinical depression closer together. |
2017-10-26 |
2023-08-13 |
Not clear |
| Christoph Kraus, Eero Castrén, Siegfried Kasper, Rupert Lanzenberge. Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression. Neuroscience and biobehavioral reviews. vol 77. 2017-10-26. PMID:28342763. |
since ketamine, physical exercise or learning enhance neuroplasticity, combinatory paradigms with selective serotonin reuptake inhibitors could enhance clinical treatment of depression. |
2017-10-26 |
2023-08-13 |
Not clear |
| Rhoda Redull. Commentary on a Cochrane Review of Antidepressants for Postpartum Depression. Nursing for women's health. vol 21. issue 3. 2017-10-26. PMID:28599737. |
results of pooled estimates of responses showed that selective serotonin reuptake inhibitors were significantly more effective than placebo in treating postpartum depression. |
2017-10-26 |
2023-08-13 |
Not clear |
| Florent Meyniel, Guy M Goodwin, Jf William Deakin, Corinna Klinge, Christine MacFadyen, Holly Milligan, Emma Mullings, Mathias Pessiglione, Raphaël Gaillar. A specific role for serotonin in overcoming effort cost. eLife. vol 5. 2017-10-23. PMID:27824554. |
this specific computational effect sheds new light on the physiological role of serotonin in behavioral regulation and on the clinical effect of drugs for depression. |
2017-10-23 |
2023-08-13 |
human |
| Youssef Sar. Commentary: Targeting NMDA Receptor and Serotonin Transporter for the Treatment of Comorbid Alcohol Dependence and Depression. Alcoholism, clinical and experimental research. vol 41. issue 2. 2017-10-23. PMID:28102547. |
commentary: targeting nmda receptor and serotonin transporter for the treatment of comorbid alcohol dependence and depression. |
2017-10-23 |
2023-08-13 |
Not clear |
| Andrew P Degnan, George O Tora, Hong Huang, David A Conlon, Carl D Davis, Umesh M Hanumegowda, Xiaoping Hou, Yi Hsiao, Joanna Hu, Rudolph Krause, Yu-Wen Li, Amy E Newton, Rick L Pieschl, Joseph Raybon, Thorsten Rosner, Jung-Hui Sun, Matthew T Taber, Sarah J Taylor, Michael K Wong, Huiping Zhang, Nicholas J Lodge, Joanne J Bronson, John E Macor, Kevin W Gillma. Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression. ACS chemical neuroscience. vol 7. issue 12. 2017-10-20. PMID:27744678. |
discovery of indazoles as potent, orally active dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors for the treatment of depression. |
2017-10-20 |
2023-08-13 |
Not clear |
| Carmelo Millón, Antonio Flores-Burgess, Manuel Narváez, Dasiel O Borroto-Escuela, Luis Santín, Belen Gago, José Angel Narváez, Kjell Fuxe, Zaida Díaz-Cabial. Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system. Brain structure & function. vol 221. issue 9. 2017-10-13. PMID:26792005. |
these results may give the basis for the development of drugs targeting potential galr1-galr2-5-ht1ar heteroreceptor complexes linked to the raphe-hippocampal 5-ht neurons for the treatment of depression. |
2017-10-13 |
2023-08-13 |
rat |
| S Alboni, R M van Dijk, S Poggini, G Milior, M Perrotta, T Drenth, N Brunello, D P Wolfer, C Limatola, I Amrein, F Cirulli, L Maggi, I Branch. Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment. Molecular psychiatry. vol 22. issue 4. 2017-10-10. PMID:26645631. |
selective serotonin reuptake inhibitors (ssris) represent the most common treatment for major depression. |
2017-10-10 |
2023-08-13 |
mouse |
| Fang Li, Jizhen Feng, Dongmei Gao, Jieqiong Wang, Chunhong Song, Sheng Wei, Mingqi Qia. Shuyu Capsules Relieve Premenstrual Syndrome Depression by Reducing 5-HT Neural plasticity. vol 2016. 2017-09-20. PMID:27725889. |
shuyu capsules relieve premenstrual syndrome depression by reducing 5-ht the effects of the shuyu capsule on 5-ht |
2017-09-20 |
2023-08-13 |
Not clear |
| Katherine M Nautiyal, Laurent Tritschler, Susanne E Ahmari, Denis J David, Alain M Gardier, René He. A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 41. issue 12. 2017-09-11. PMID:27353308. |
the effects of serotonin (5-ht) on anxiety and depression are mediated by a number of 5-ht receptors, including autoreceptors that act to inhibit 5-ht release. |
2017-09-11 |
2023-08-13 |
Not clear |
| Jonathan A Coleman, Evan M Green, Eric Gouau. Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram. Journal of visualized experiments : JoVE. issue 117. 2017-09-11. PMID:27929454. |
s-citalopram is a drug used to treat depression and anxiety by binding to the serotonin transporter with high-affinity, blocking serotonin reuptake. |
2017-09-11 |
2023-08-13 |
human |
| Gazi Yildiz, Mehmet Baki Senturk, Pinar Yildiz, Yusuf Cakmak, Mehmet Sukru Budak, Erbil Caka. Serum serotonin, leptin, and adiponectin changes in women with postpartum depression: controlled study. Archives of gynecology and obstetrics. vol 295. issue 4. 2017-09-11. PMID:28224268. |
serum serotonin, leptin, and adiponectin changes in women with postpartum depression: controlled study. |
2017-09-11 |
2023-08-13 |
Not clear |
| Gazi Yildiz, Mehmet Baki Senturk, Pinar Yildiz, Yusuf Cakmak, Mehmet Sukru Budak, Erbil Caka. Serum serotonin, leptin, and adiponectin changes in women with postpartum depression: controlled study. Archives of gynecology and obstetrics. vol 295. issue 4. 2017-09-11. PMID:28224268. |
the relationship between serum serotonin concentration and depression is well known, but there are no enough data regarding the serum change of leptin and adiponectin. |
2017-09-11 |
2023-08-13 |
Not clear |
| S Eskeland, L Tanum, J A Halvorse. Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram. Clinical and experimental dermatology. vol 41. issue 5. 2017-09-08. PMID:27037523. |
we report a case of dpu and depression in a patient, which responded favourably to treatment with the selective serotonin reuptake inhibitor (ssri) escitalopram. |
2017-09-08 |
2023-08-13 |
Not clear |
| Antonio Flores-Burgess, Carmelo Millón, Belén Gago, Manuel Narváez, Dasiel O Borroto-Escuela, Guadalupe Mengod, José Angel Narváez, Kjell Fuxe, Luis Santín, Zaida Díaz-Cabial. Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression. Neuropharmacology. vol 118. 2017-09-05. PMID:28288814. |
the pharmacological treatment of major depression is mainly based on drugs elevating serotonergic (5-ht) activity. |
2017-09-05 |
2023-08-13 |
rat |
| Antonio Flores-Burgess, Carmelo Millón, Belén Gago, Manuel Narváez, Dasiel O Borroto-Escuela, Guadalupe Mengod, José Angel Narváez, Kjell Fuxe, Luis Santín, Zaida Díaz-Cabial. Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression. Neuropharmacology. vol 118. 2017-09-05. PMID:28288814. |
specifically, selective 5-ht reuptake inhibitors, including fluoxetine (flx), are the most commonly used for treatment of major depression. |
2017-09-05 |
2023-08-13 |
rat |
| Jacob P R Jacobsen, Andrew D Krystal, K Ranga R Krishnan, Marc G Caro. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale. Trends in pharmacological sciences. vol 37. issue 11. 2017-09-04. PMID:27692695. |
serotonin transporter (sert) inhibitors treat depression by elevating brain extracellular 5-hydroxytryptamine (5-ht |
2017-09-04 |
2023-08-13 |
Not clear |
| Meisha L Raven, Alexander L Ringeisen, Angela R McAllister, Daniel W Knoc. Reversible Cerebral Vasoconstriction Syndrome Presenting With Visual Field Defects. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. vol 36. issue 2. 2017-09-01. PMID:26807800. |
a 45-year-old woman with a history of depression and anxiety, treated with selective serotonin reuptake inhibitors (ssris), experienced acute, recurrent, and severe bifrontal headaches. |
2017-09-01 |
2023-08-13 |
Not clear |
| Mary Gemmel, Ine Rayen, Eva van Donkelaar, Tiffany Loftus, Harry W Steinbusch, Nikolaos Kokras, Christina Dalla, Jodi L Pawlusk. Gestational stress and fluoxetine treatment differentially affect plasticity, methylation and serotonin levels in the PFC and hippocampus of rat dams. Neuroscience. vol 327. 2017-08-31. PMID:27060483. |
increased prevalence of depression during the perinatal period has resulted in frequent selective serotonin reuptake inhibitor (ssri) antidepressant treatment; however the effects of such medications on the maternal brain remain limited. |
2017-08-31 |
2023-08-13 |
rat |